Search Results for "Supply%20Chain"

Research 12/20/2021
Comparing Factors that Influence Pharmaceutical Pricing and Access in the US and five other Countries
Drug prices in the United States are some of the highest in the world, which has triggered several policy proposals aimed at adopting pricing strategies used by other countries.
Person 11/10/2020
Jennifer C. Chen, MPH
Senior Project Portfolio Manager, Center for Health Policy and Outcomes, Memorial Sloan Kettering Cancer Center
Research 05/19/2020
Blueprints for Indication-Specific Pricing
Several approaches that rewire existing reimbursement conventions as alternatives to facilitate ISP are proposed.
Research 05/01/2020
Pharmaceutical Products and Their Value
Steep increases in prices and spending on prescription drugs in the United States have triggered public outrage and questions about their value.
News 01/31/2019
Dr. Bach Testifies at U.S. Senate Committee on Finance's First Hearing of Session
Dr. Peter Bach, alongside Kathy Sego, Dr. Douglas Holtz-Eakin, and Dr. Mark Miller, testified before U.S. Senate Finance Committee at its first hearing of the session, Drug Pricing in America: A Prescription for Change, Part I.
Research 08/01/2018
Spending On Prescription Drugs In The US: Where Does All The Money Go?
Supply chain intermediaries, or “middlemen,” are being blamed for capturing much of the money that is often categorized as drug spending.
News 05/10/2018
60 Minutes: The Rockford File
Dr. Bach contributed to The Rockford File segment following one drug, HP Acthar, that threatened to financially cripple the city of Rockford, Illinois.
Research 05/30/2017
Association of Rebates in Part D with Patient OOP and Federal Spending
The way Medicare Part D's benefit design shows that rebates actually increase patients' out-of-pocket costs while shifting spending from plan sponsors and manufacturers to Medicare.
No Results Found